In-hospital and Post-discharge Status in COVID-19 Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGALAS, Filomena Regina Barbosa Gomes
dc.contributor.authorFERNANDES, Henrique Mateus
dc.contributor.authorFRANCI, Andre
dc.contributor.authorROSARIO, Andre Loureiro
dc.contributor.authorSARETTA, Roberta
dc.contributor.authorJR, Laerte Patore
dc.contributor.authorBARACIOLI, Luciano Moreira
dc.contributor.authorMORAES, Juliana Gil
dc.contributor.authorMOURAO, Matheus Moraes
dc.contributor.authorCOSTA, Livia do Valle
dc.contributor.authorNASCIMENTO, Teresa Cristina Dias Cunha
dc.contributor.authorDRAGER, Luciano Ferreira
dc.contributor.authorDIAS, Marcia Rodrigues Sundin
dc.contributor.authorKALIL-FILHO, Roberto
dc.date.accessioned2023-06-21T14:03:20Z
dc.date.available2023-06-21T14:03:20Z
dc.date.issued2023
dc.description.abstractFew data from Latin American centers on clinical outcomes in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome who required extracorporeal membrane oxygenation (ECMO) are published. Moreover, clinical and functional status after hospital discharge remains poorly explored in these patients. We evaluated in-hospital outcomes of severe COVID-19 patients who received ECMO support in two Brazilian hospitals. In one-third of the survivors, post-acute COVID-19 syndrome (PACS), quality of life, anxiety, depression, and return to work were evaluated. Eighty-five patients were included and in-hospital mortality was 47%. Age >65 years (HR: 4.8; 95% confidence interval [CI]: 1.4-16.4), diabetes (HR: 6.0; 95% CI: 1.8-19.6), ECMO support duration (HR: 1.08; 95% CI: 1.05-1.12) and dialysis initiated after ECMO (HR: 3.4; 95% CI: 1.1-10.8) were independently associated with higher in-hospital mortality and mechanical ventilation (MV) duration before ECMO was not (HR: 1.18; 95% CI: 0.71-2.09). PACS-related symptoms were reported by two-thirds and half of patients at 30- and 90-days post-discharge, respectively. The median EQ-5D score was 0.85 (0.70-1.00) and 0.77 (0.66-1.00) at 30 and 90 days. Of the 15 responders, all previously working patients, except one, have returned to work at 90 days. In conclusion, in-hospital mortality in a large Latin American cohort was comparable to the Global extracorporeal life support organization registry.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationASAIO JOURNAL, v.69, n.5, p.E181-E187, 2023
dc.identifier.doi10.1097/MAT.0000000000001919
dc.identifier.eissn1538-943X
dc.identifier.issn1058-2916
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/53763
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINSeng
dc.relation.ispartofAsaio Journal
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINSeng
dc.subjectacute respiratory distress syndromeeng
dc.subjectCOVID-19eng
dc.subjectcritical careeng
dc.subjectextracorporeal membrane oxygenationeng
dc.subjectpost-acute COVID-19 syndromeeng
dc.subject.otherlifeeng
dc.subject.otherdepressioneng
dc.subject.othersurvivorseng
dc.subject.wosEngineering, Biomedicaleng
dc.subject.wosTransplantationeng
dc.titleIn-hospital and Post-discharge Status in COVID-19 Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenationeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalFERNANDES, Henrique Mateus:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalFRANCI, Andre:Hosp Sirio Libanes, Sao Paulo, Brazil; Hosp Sirio Libanes, Ctr Cardiol, R Adma Jafet,91 Bela Vista,7th Floor,Block D, Sao Paulo, Brazil
hcfmusp.author.externalROSARIO, Andre Loureiro:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalSARETTA, Roberta:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalJR, Laerte Patore:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalMORAES, Juliana Gil:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalMOURAO, Matheus Moraes:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalCOSTA, Livia do Valle:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalNASCIMENTO, Teresa Cristina Dias Cunha:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.author.externalDIAS, Marcia Rodrigues Sundin:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcFILOMENA REGINA BARBOSA GOMES GALAS
hcfmusp.contributor.author-fmusphcLUCIANO MOREIRA BARACIOLI
hcfmusp.contributor.author-fmusphcLUCIANO FERREIRA DRAGER
hcfmusp.contributor.author-fmusphcROBERTO KALIL FILHO
hcfmusp.description.beginpageE181
hcfmusp.description.endpageE187
hcfmusp.description.issue5
hcfmusp.description.volume69
hcfmusp.origemWOS
hcfmusp.origem.pubmed37126226
hcfmusp.origem.scopus2-s2.0-85158891859
hcfmusp.origem.wosWOS:000981065200002
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceArroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139eng
hcfmusp.relation.referenceBadulak J, 2021, ASAIO J, V67, P485, DOI 10.1097/MAT.0000000000001422eng
hcfmusp.relation.referenceBarbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0eng
hcfmusp.relation.referenceCombes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385eng
hcfmusp.relation.referenceDiaz RA, 2021, AM J RESP CRIT CARE, V204, P34, DOI 10.1164/rccm.202011-4166OCeng
hcfmusp.relation.referenceExtracorporeal Life Support Organization (ELSO), USeng
hcfmusp.relation.referenceFernandes J, 2021, ACTA MEDICA PORT, V34, P601, DOI 10.20344/amp.16277eng
hcfmusp.relation.referenceGoligher EC, 2018, JAMA-J AM MED ASSOC, V320, P2251, DOI 10.1001/jama.2018.14276eng
hcfmusp.relation.referenceGrasselli G, 2019, ANESTHESIOLOGY, V130, P572, DOI 10.1097/ALN.0000000000002624eng
hcfmusp.relation.referenceHenry BM, 2020, J CRIT CARE, V58, P27, DOI 10.1016/j.jcrc.2020.03.011eng
hcfmusp.relation.referenceHermann M, 2022, ANN INTENSIVE CARE, V12, DOI 10.1186/s13613-022-00980-3eng
hcfmusp.relation.referenceHodgson CL, 2012, CRIT CARE, V16, DOI 10.1186/cc11811eng
hcfmusp.relation.referenceKaragiannidis C, 2021, AM J RESP CRIT CARE, V204, P991, DOI 10.1164/rccm.202105-1145LEeng
hcfmusp.relation.referenceKroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3Ceng
hcfmusp.relation.referenceKurniawati ER, 2021, QUAL LIFE RES, V30, P2123, DOI 10.1007/s11136-021-02834-0eng
hcfmusp.relation.referenceMasur J, 2020, AM J NEURORADIOL, V41, P2009, DOI 10.3174/ajnr.A6728eng
hcfmusp.relation.referenceMcPeake J, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2021-001080eng
hcfmusp.relation.referenceMenezes RD, 2015, QUAL LIFE RES, V24, P2761, DOI 10.1007/s11136-015-0994-7eng
hcfmusp.relation.referenceMunshi L, 2019, LANCET RESP MED, V7, P163, DOI 10.1016/S2213-2600(18)30452-1eng
hcfmusp.relation.referenceOlivier PY, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03800-5eng
hcfmusp.relation.referencePeek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2eng
hcfmusp.relation.referenceRajajee Venkatakrishna, 2021, Crit Care Explor, V3, pe0537, DOI 10.1097/CCE.0000000000000537eng
hcfmusp.relation.referenceRamanathan K, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03634-1eng
hcfmusp.relation.referenceRilinger J, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03821-0eng
hcfmusp.relation.referenceSchmidt M, 2014, AM J RESP CRIT CARE, V189, P1374, DOI 10.1164/rccm.201311-2023OCeng
hcfmusp.relation.referenceSkapinakis Petros, 2007, Evid Based Med, V12, P149, DOI 10.1136/ebm.12.5.149eng
hcfmusp.relation.referenceTzotzos SJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03240-7eng
hcfmusp.relation.referenceUsman AA, 2020, J CARDIOTHOR VASC AN, V34, P3006, DOI 10.1053/j.jvca.2020.07.063eng
hcfmusp.relation.referenceWang ZY, 2017, CHINESE MED J-PEKING, V130, P1161, DOI 10.4103/0366-6999.205847eng
hcfmusp.relation.referenceWilliamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4eng
hcfmusp.relation.referenceWorld Health Organization, 2022, TRACK SARS COV 2 VAReng
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication408ce1dc-2020-48e8-acbf-a5edc4261285
relation.isAuthorOfPublicationa037dd7e-166e-491f-afae-191e837aa276
relation.isAuthorOfPublication45056c2e-919d-4fc1-97d3-356e54fe3385
relation.isAuthorOfPublicationc934e4bf-7bb3-4e4d-aaac-07d8be41a3ac
relation.isAuthorOfPublication.latestForDiscovery408ce1dc-2020-48e8-acbf-a5edc4261285
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_GALAS_Inhospital_and_Postdischarge_Status_in_COVID19_Patients_With_2023.PDF
Tamanho:
298.79 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Carregar mais